Physician profile
Anwar Wassel
NPI 1376707521
$46,714.99
in general payments reported to CMS, 2019-2025
42 companies · $4,164 in 2025
The $4,164 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,419 · 2020: $2,799 · 2021: $13K · 2022: $9,752 · 2023: $9,723 · 2024: $5,813 · 2025: $4,164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $6,160 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,450.00 |
| Food and Beverage | $6,159.81 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $36,594.00 | 2019-2025 | Breztri, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $1,869.17 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Harmony Biosciences LLC | $1,150.95 | 2020-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,002.50 | 2019-2025 | Ofev, Jardiance |
| Genzyme Corporation | $800.71 | 2019-2025 | |
| Electromed, INC. | $731.61 | 2021-2025 | Smartvest |
| Grifols USA, LLC | $718.35 | 2019-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $700.34 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $497.82 | 2019-2025 | Dupixent |
| Amgen INC. | $442.78 | 2019-2025 | Tezspire, Uplizna, Krystexxa |
| Philips North America LLC | $339.00 | 2019-2024 | (Ak6) Vest Therapy |
| Bayer Healthcare Pharmaceuticals INC. | $192.56 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $175.11 | 2020-2025 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $153.07 | 2022-2025 | Glassia |
| Teva Pharmaceuticals USA, INC. | $149.79 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anwar Wassel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.